These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6178236)

  • 21. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Ito A; Kuhara A; Nakata S; Shirakura R; Miyata M; Matsuda H
    Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059
    [No Abstract]   [Full Text] [Related]  

  • 22. The primacy of humoral antibody (complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity) in concordant xenograft rejection.
    Araneda D; Thomas FT; Ljung T; Cekada E; Pittman K
    Transplant Proc; 1995 Feb; 27(1):268-9. PubMed ID: 7878997
    [No Abstract]   [Full Text] [Related]  

  • 23. T cell stimulating growth factors.
    Immunol Rev; 1980; 51():1-357. PubMed ID: 6968712
    [No Abstract]   [Full Text] [Related]  

  • 24. Microlymphocytotoxicity assay to assess reactivity of rodent sera to large animal T lymphocytes.
    Betz JK; Ketchum RJ; Levy MM; Park DH; Perloff JR; Grodberg JB; Kearns J; Zmijewski CM; Brayman KL
    Transplant Proc; 1994 Dec; 26(6):3449-50. PubMed ID: 7998216
    [No Abstract]   [Full Text] [Related]  

  • 25. Possible contribution of the complement system to the inflammatory state.
    Hadding U
    Agents Actions Suppl; 1980; 7():24-32. PubMed ID: 7018199
    [No Abstract]   [Full Text] [Related]  

  • 26. [Current status of the problem on child immunity. 1. Natural, nonspecific protective factors in the child's body].
    Afonina LG
    Med Sestra; 1978 May; 37(5):6-10. PubMed ID: 248119
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.
    Lee FH; Currie D; Hwang KM
    Cancer Res; 1984 Dec; 44(12 Pt 1):5491-8. PubMed ID: 6208997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Para-immunity after oral antigen administration].
    Raettig H
    Fortschr Med; 1982 May; 100(17):792-4. PubMed ID: 6284619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activating factors for nonspecific and antibody-dependent cytotoxicity by human and murine mononuclear phagocytes.
    Ralph P
    Lymphokine Res; 1984; 3(4):153-61. PubMed ID: 6208440
    [No Abstract]   [Full Text] [Related]  

  • 30. Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML.
    Huber C; Pfister R; Stingl G
    Clin Exp Immunol; 1982 Dec; 50(3):525-33. PubMed ID: 6219834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural immunity. History, present, and future.
    Lotzová E
    Nat Immun Cell Growth Regul; 1983-1984; 3(1):1-6. PubMed ID: 6379426
    [No Abstract]   [Full Text] [Related]  

  • 32. Paramunity after oral immunization.
    Raettig H
    Poumon Coeur; 1982; 38(5):285-8. PubMed ID: 7155998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunity against cancer--a critical review of recent progress--].
    Yamamura Y
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):311-9. PubMed ID: 6192758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement: a member of the innate immune system.
    Schifferli JA
    Springer Semin Immunopathol; 2005 Nov; 27(3):273-5. PubMed ID: 16208472
    [No Abstract]   [Full Text] [Related]  

  • 35. [Perinatal infections. Fetal and newborn immunology in perinatal infection].
    Drews K; Słomko Z; Breborowicz G
    Przegl Epidemiol; 1994; 48(4):377-83. PubMed ID: 7597174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The lymphokine-mediated activation of effector cells in the natural resistance system induced by gamma-interferon].
    Fil'chakov FV; Fil'chakov IV; Grinevich IuA; Martynenko SV; Ivanenko VK
    Fiziol Zh (1994); 1995; 41(3-4):14-20. PubMed ID: 8777749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Scientific development in the field of drug enhancement of nonantigenic body-specific resistance].
    Mayr A
    Tierarztl Prax; 1982; 10(4):451-63. PubMed ID: 6186051
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanisms of resistance to the intracellular protozoan Encephalitozoon cuniculi in mice.
    Schmidt EC; Shadduck JA
    J Immunol; 1984 Nov; 133(5):2712-9. PubMed ID: 6434635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
    Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
    J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alloantibodies and outcomes of deceased donor kidney allografts.
    Cinti P; Pretagostini R; Lai Q; Tamburro ML; Rossi M; Poli L; Berloco P
    Hum Immunol; 2009 Aug; 70(8):651-4. PubMed ID: 19527761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.